PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease

Clinical Trial Authorisation application granted for combined drug PK051 targeting amyloid deposits associated with Alzheimer’s Disease.

Medscape Launches Free AI Medical Scribe for Physicians

What You Should Know: – Medscape has launched a free AI medical scribe for US physicians, the latest entry in a developing space of artificial intelligence tools

August 30, 2024

Adding Regorafenib in First-Line ‘Promising’ in Gastric Cancer

Adding regorafenib (Stivarga) to a standard first-line chemoimmunotherapy regimen for HER2-negative metastatic esophagogastric cancer demonstrated “promising” activity in a single-arm phase II study, according to

September 6, 2023

University Hospitals receives multiple stroke care awards

University Hospitals (UH) has received numerous American Heart Association/American Stroke Association Get With The Guidelines – Stroke achievement awards for demonstrating commitment to following the

July 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.